Infant feeding: A critical look at infant formulas

Current Opinion in Pediatrics

Volumn 12, Issue 5, 2000, Pages 469-476

  Motil, Kathleen J ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c CHILDREN S NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOSE; LONG CHAIN FATTY ACID; NUCLEOTIDE; POLYUNSATURATED FATTY ACID; SOYBEAN PROTEIN;

ARTIFICIAL MILK; CARBOHYDRATE INTAKE; DIETARY INTAKE; FAT INTAKE; HUMAN; INFANT; INFANT FEEDING; INFANT NUTRITION; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW;

ALUMINUM; ARACHIDONIC ACID; DIGESTION; FATTY ACIDS, UNSATURATED; HUMANS; INFANT; INFANT FOOD; INFANT, NEWBORN; LACTOSE; LIPID METABOLISM; PROTEINS; SOYBEAN PROTEINS;

EID: 0033824893     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200010000-00009     Document Type: Review

References (56)

1. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant formula milk: A randomized trial
2. A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants: A randomised, controlled trial
3. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants
4. Essential fat requirements of preterm infants
5. n-3 Polyunsaturated fatty acid requirements of term infants
6. Long-chain polyunsaturated fatty acids and development of human infants
7. The role of long chain polyunsaturated fatty acids (LCPUFA) in neonatal nutrition
8. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants
9. Evaluation of a long-chain polyunsaturated fatty acid supplemented formula on growth, tolerance, and plasma lipids in preterm infants up to 48 weeks postconceptional age
10. Assessment of the efficacious dose of arachnidonic and docosahexaenoic acids in preterm infant formulas: Fatty acid content of erythrocyte lipids
11. Assessment of feeding different amounts of arachidonic and docosahexaenoic acids in preterm infant formulas on the fatty acid content of lipoprotein lipids
12. First year growth of preterm infants fed standard compared to marine oil (fish oil) n-3 supplemented formula
13. Dietary long-chain polyunsaturated fatty acids do not influence growth of term infants: A randomized clinical trial
14. Fish oil: For use in infant formula?
15. Fish oil supplementation does not impair the gut immune response to Trichinella spiralis infection in rats
16. Effect of long chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia
17. Formula tolerance in post-breastfed and exclusively formula-fed infants
18. Double-blind, randomized trial of a synthetic triacylglycerol in formula-fed term infants: Effects on stool biochemistry, stool characteristics, and bone mineralization
19. Plasma lipoprotein fatty acids are altered by the positional distribution of fatty acids in infant formula triacylglycerols and human milk
20. Protein requirements of infants and childre
21. Influence of macronutrients on adiposity development: A follow-up study of nutrition and growth from 10 months to 8 years
22. Infant formula with protein-energy ratio of 1.76 g/100 kcal is adequate but may not be safe
23. Protein intake and metabolism in formula-fed infants given Swedish or Italian weaning foods
24. Growth and nutrient intake in 3-to 12-month-old infants fed human milk or formulas with varying protein concentrations
25. Feeding strategies for premature infants: Beneficial outcomes of feeding fortified human milk versus preterm formula
26. Changes in growth and metabolism in very low birthweight infants fed with fortified breast milk
27. Individualized protein fortification of human milk for preterm infants: Comparison of ultrafiltrated human milk protein and a bovine whey fortifier
28. Postprandial plasma amino acids in preterm infants: Influence of the protein source
29. Nutritional evaluation of protein hydrolysate formulas
30. Protein hydrolysate formula maintains homeostasis of plasma amino acids in preterm infants
31. Evaluation of the development of intestinal function in rats reared on hydrolyzed or native protein-based milk formula
32. Intestinal lactobezoars in twins receiving a reconstituted elemental formula
33. Soy protein-based formulas: Recommendations for use in infant feeding
34. Growth of newborn, term infants fed soy formulas for 1 year
35. The story of soy formula feeding in infants: A road paved with good intentions
36. Isoflavones, soy-based infant formulas, and relevance to endocrine function
37. Isoflavone ontent of infant formulas and the metabolic fate of these phytoestrogens in early life
38. Exposure of infants to phyto-estrogens from soy-based formula
39. Phytoestrogens in soy-based infant foods: Concentrations, daily intake, and possible biological effects
40. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas
41. Total potentially available nucleotides of human milk by stage of lactation
42. Dietary nucleotides: Effects on the immune and gastrointestinal systems
43. Effects of the addition of nucleotides to an adapted milk formula on the microbial pattern of faeces in at-term newborn infants
44. Effect of dietary nucreotide supplementation on diarrheal disease in infants
45. Modulation of the immune system by human milk and infant formula containing nucleotides
46. Breast milk versus infant formulas: Effects on intestinal blood flow in neonates
47. Effect of carbohydrates on calcium absorption in premature infants
48. Digestion, absorption, and fermentation of carbohydrates in the newborn
49. Can the elimination of lactose from formula improve feeding tolerance in premature infants?
50. Use of nonhuman milks in dietary management of young children with acute diarrhea: A meta-analysis of clinical trials
51. Comparison of soy-based formulas with lactose and with sucrose in the treatment of acute diarrhea in infants
52. Encephalopathy in childhood secondary to aluminum toxicity
53. Aluminum loading in children with chronic renal failure
54. Aluminum toxicity in infants and children
55. Aluminum contents of human milk, cow's milk, and infant formulas
56. Evaluation of certain food additives and contaminants: Thirty-third report of the joint FAO/WHO Expert Committee on food additives